• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

E2F1 as a molecular drug target in ovarian cancer.

作者信息

Farra Rossella, Dapas Barbara, Grassi Mario, Benedetti Fabio, Grassi Gabriele

机构信息

a Department of Life Sciences , Cattinara University Hospital, Trieste University , Trieste , Italy.

b Department of Engineering and Architecture , University of Trieste , Trieste , Italy.

出版信息

Expert Opin Ther Targets. 2019 Mar;23(3):161-164. doi: 10.1080/14728222.2019.1579797. Epub 2019 Feb 8.

DOI:10.1080/14728222.2019.1579797
PMID:30724632
Abstract
摘要

相似文献

1
E2F1 as a molecular drug target in ovarian cancer.E2F1作为卵巢癌的分子药物靶点。
Expert Opin Ther Targets. 2019 Mar;23(3):161-164. doi: 10.1080/14728222.2019.1579797. Epub 2019 Feb 8.
2
E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets.E2F1与核因子κB：炎症相关癌症的关键介质及潜在治疗靶点
Curr Cancer Drug Targets. 2016;16(9):765-772. doi: 10.2174/1568009616666160216130755.
3
[Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma].ARHI、STAT3和E2F1在卵巢浆液性癌中的表达及临床意义
Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):905-9.
4
RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.RBM38 是 E2F1 的直接转录靶标，可限制 E2F1 诱导的增殖。
Mol Cancer Res. 2012 Sep;10(9):1169-77. doi: 10.1158/1541-7786.MCR-12-0331. Epub 2012 Jul 13.
5
E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.E2F-1靶向miR-519d以调控Ras同源基因家族成员C的表达。
Oncotarget. 2017 Feb 28;8(9):14777-14793. doi: 10.18632/oncotarget.14833.
6
Making the most of every option in the treatment of ovarian cancer.充分利用卵巢癌治疗中的每一种选择。
Expert Rev Anticancer Ther. 2016 Nov;16(sup1):1. doi: 10.1080/14737140.2016.1243476.
7
The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.抑癌基因 maspin 介导 E2F1 诱导的癌细胞对化疗的敏感性。
Mol Cancer Res. 2010 Mar;8(3):363-72. doi: 10.1158/1541-7786.MCR-09-0137. Epub 2010 Mar 2.
8
Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs.黏液性卵巢癌：当前的治疗靶点、临床前进展及实验性药物
Expert Opin Investig Drugs. 2019 Dec;28(12):1025-1029. doi: 10.1080/13543784.2019.1693999. Epub 2019 Nov 19.
9
Eliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistance.消除卵巢癌干细胞：卵巢癌化疗耐药的潜在治疗靶点。
Curr Protein Pept Sci. 2015;16(4):270-8. doi: 10.2174/138920371604150429151457.
10
New drugs in ovarian cancer.卵巢癌的新药
Clin Adv Hematol Oncol. 2015 Apr;13(4):223-5.

引用本文的文献

1
Data-Driven Discovery of a Key Regulator Cyclin A2 as a Promising Therapeutic Target in Hormone-Sensitive Cancers.数据驱动发现关键调节因子细胞周期蛋白A2作为激素敏感性癌症中有前景的治疗靶点
Mol Biotechnol. 2025 Sep 11. doi: 10.1007/s12033-025-01504-7.
2
The E2F1/SBK1 axis activates the Notch signaling pathway to accelerate the malignant progression of breast cancer.E2F1/SBK1轴激活Notch信号通路以加速乳腺癌的恶性进展。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 27. doi: 10.1007/s00210-025-04251-3.
3
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.
药物2c及其衍生物对卵巢癌细胞作用的体外和体内评价
Pharmaceutics. 2024 May 15;16(5):664. doi: 10.3390/pharmaceutics16050664.
4
E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells.E2F1介导同居的耐药和敏感卵巢癌细胞之间的竞争、增殖以及对顺铂的反应。
Front Oncol. 2024 Jan 26;14:1304691. doi: 10.3389/fonc.2024.1304691. eCollection 2024.
5
Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer.鉴定血清 miR-1246 和 miR-150-5p 作为高级别浆液性卵巢癌的新型诊断生物标志物。
Sci Rep. 2023 Nov 7;13(1):19287. doi: 10.1038/s41598-023-45317-7.
6
PITX1 plays essential functions in cancer.PITX1在癌症中发挥着重要作用。
Front Oncol. 2023 Sep 29;13:1253238. doi: 10.3389/fonc.2023.1253238. eCollection 2023.
7
GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.GSG2 通过 MDM2 介导的 E2F1 泛素化促进人类乳腺癌的进展。
J Transl Med. 2023 Aug 3;21(1):523. doi: 10.1186/s12967-023-04358-2.
8
Integration analysis of senescence-related genes to predict prognosis and immunotherapy response in soft-tissue sarcoma: evidence based on machine learning and experiments.衰老相关基因的整合分析以预测软组织肉瘤的预后和免疫治疗反应：基于机器学习和实验的证据
Front Pharmacol. 2023 Jul 11;14:1229233. doi: 10.3389/fphar.2023.1229233. eCollection 2023.
9
EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4.EZH2 通过 E2F1、GLI1、CDK3 和 Mcm4 调控胰腺癌细胞。
Hereditas. 2023 May 17;160(1):23. doi: 10.1186/s41065-023-00280-1.
10
CDC25A inhibition suppresses cell proliferation and induces G/S‑phase cell cycle arrest in nasopharyngeal carcinoma.CDC25A 抑制可抑制鼻咽癌细胞增殖并诱导 G/S 期细胞周期停滞。
Mol Med Rep. 2023 May;27(5). doi: 10.3892/mmr.2023.12996. Epub 2023 Apr 13.